201 related articles for article (PubMed ID: 26583432)
21. Osteoblast-derived factors promote metastatic potential in human prostate cancer cells, in part via non-canonical transforming growth factor β (TGFβ) signaling.
Karlsson T; Sundar R; Widmark A; Landström M; Persson E
Prostate; 2018 May; 78(6):446-456. PubMed ID: 29383751
[TBL] [Abstract][Full Text] [Related]
22. Specific interactions between Smad proteins and AP-1 components determine TGFβ-induced breast cancer cell invasion.
Sundqvist A; Zieba A; Vasilaki E; Herrera Hidalgo C; Söderberg O; Koinuma D; Miyazono K; Heldin CH; Landegren U; Ten Dijke P; van Dam H
Oncogene; 2013 Aug; 32(31):3606-15. PubMed ID: 22926518
[TBL] [Abstract][Full Text] [Related]
23. Nuclear translocation of type I transforming growth factor β receptor confers a novel function in RNA processing.
Chandra M; Zang S; Li H; Zimmerman LJ; Champer J; Tsuyada A; Chow A; Zhou W; Yu Y; Gao H; Ren X; Lin RJ; Wang SE
Mol Cell Biol; 2012 Jun; 32(12):2183-95. PubMed ID: 22473997
[TBL] [Abstract][Full Text] [Related]
24. The oncoprotein c-ski functions as a direct antagonist of the transforming growth factor-{beta} type I receptor.
Ferrand N; Atfi A; Prunier C
Cancer Res; 2010 Nov; 70(21):8457-66. PubMed ID: 20959473
[TBL] [Abstract][Full Text] [Related]
25. βarrestin2 interacts with TβRII to regulate Smad-dependent and Smad-independent signal transduction.
McLean S; Bhattacharya M; Di Guglielmo GM
Cell Signal; 2013 Jan; 25(1):319-31. PubMed ID: 23069267
[TBL] [Abstract][Full Text] [Related]
26. A dual prognostic role for the TGFβ receptors in human breast cancer.
Hachim IY; Hachim MY; López-Ozuna VM; Ali S; Lebrun JJ
Hum Pathol; 2016 Nov; 57():140-151. PubMed ID: 27445263
[TBL] [Abstract][Full Text] [Related]
27. Transforming Growth Factor β Signaling in Colorectal Cancer Cells With Microsatellite Instability Despite Biallelic Mutations in TGFBR2.
de Miranda NF; van Dinther M; van den Akker BE; van Wezel T; ten Dijke P; Morreau H
Gastroenterology; 2015 Jun; 148(7):1427-37.e8. PubMed ID: 25736321
[TBL] [Abstract][Full Text] [Related]
28. Characterization of TGF-beta-regulated interleukin-8 expression in human prostate cancer cells.
Lu S; Dong Z
Prostate; 2006 Jun; 66(9):996-1004. PubMed ID: 16541418
[TBL] [Abstract][Full Text] [Related]
29. aPKC alters the TGFβ response in NSCLC cells through both Smad-dependent and Smad-independent pathways.
Gunaratne A; Chan E; El-Chabib TH; Carter D; Di Guglielmo GM
J Cell Sci; 2015 Feb; 128(3):487–98. PubMed ID: 25501807
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway.
Tu X; Zhang H; Zhang J; Zhao S; Zheng X; Zhang Z; Zhu J; Chen J; Dong L; Zang Y; Zhang J
J Pathol; 2014 Sep; 234(1):46-59. PubMed ID: 24817606
[TBL] [Abstract][Full Text] [Related]
31. Ligand-dependent and -independent interactions with the transforming growth factor type II and I receptor subunits reside in the aminoterminal portion of the ectodomain of the type III subunit.
Taniguchi A; Matsuzaki K; Nakano K; Kan M; McKeehan WL
In Vitro Cell Dev Biol Anim; 1998 Mar; 34(3):232-8. PubMed ID: 9557941
[TBL] [Abstract][Full Text] [Related]
32. Autocrine growth inhibition by transforming growth factor beta-1 (TGFbeta-1) in human neuroendocrine tumour cells.
Wimmel A; Wiedenmann B; Rosewicz S
Gut; 2003 Sep; 52(9):1308-16. PubMed ID: 12912863
[TBL] [Abstract][Full Text] [Related]
33. USP4 is regulated by AKT phosphorylation and directly deubiquitylates TGF-β type I receptor.
Zhang L; Zhou F; Drabsch Y; Gao R; Snaar-Jagalska BE; Mickanin C; Huang H; Sheppard KA; Porter JA; Lu CX; ten Dijke P
Nat Cell Biol; 2012 Jun; 14(7):717-26. PubMed ID: 22706160
[TBL] [Abstract][Full Text] [Related]
34. Breast cancer anti-estrogen resistance 3 inhibits transforming growth factor β/Smad signaling and associates with favorable breast cancer disease outcomes.
Guo J; Canaff L; Rajadurai CV; Fils-Aimé N; Tian J; Dai M; Korah J; Villatoro M; Park M; Ali S; Lebrun JJ
Breast Cancer Res; 2014 Dec; 16(6):476. PubMed ID: 25499443
[TBL] [Abstract][Full Text] [Related]
35. Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts.
Mori Y; Ishida W; Bhattacharyya S; Li Y; Platanias LC; Varga J
Arthritis Rheum; 2004 Dec; 50(12):4008-21. PubMed ID: 15593186
[TBL] [Abstract][Full Text] [Related]
36. Sequential gonadotropin treatment of immature mice leads to amplification of transforming growth factor beta action, via upregulation of receptor-type 1, Smad 2 and 4, and downregulation of Smad 6.
Guéripel X; Benahmed M; Gougeon A
Biol Reprod; 2004 Mar; 70(3):640-8. PubMed ID: 14585817
[TBL] [Abstract][Full Text] [Related]
37. TGFβ-induced phosphorylation of Par6 promotes migration and invasion in prostate cancer cells.
Mu Y; Zang G; Engström U; Busch C; Landström M
Br J Cancer; 2015 Mar; 112(7):1223-31. PubMed ID: 25756394
[TBL] [Abstract][Full Text] [Related]
38. A kinase subdomain of transforming growth factor-beta (TGF-beta) type I receptor determines the TGF-beta intracellular signaling specificity.
Feng XH; Derynck R
EMBO J; 1997 Jul; 16(13):3912-23. PubMed ID: 9233801
[TBL] [Abstract][Full Text] [Related]
39. Transforming growth factor-β suppresses metastasis in a subset of human colon carcinoma cells.
Simms NA; Rajput A; Sharratt EA; Ongchin M; Teggart CA; Wang J; Brattain MG
BMC Cancer; 2012 Jun; 12():221. PubMed ID: 22672900
[TBL] [Abstract][Full Text] [Related]
40. Syntenin regulates TGF-β1-induced Smad activation and the epithelial-to-mesenchymal transition by inhibiting caveolin-mediated TGF-β type I receptor internalization.
Hwangbo C; Tae N; Lee S; Kim O; Park OK; Kim J; Kwon SH; Lee JH
Oncogene; 2016 Jan; 35(3):389-401. PubMed ID: 25893292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
